Dosage Regimen For Anti-Mif Antibodies

Patent No. EP3277718 (titled "Dosage Regimen For Anti-Mif Antibodies") was filed by Baxalta on Mar 31, 2016. The application was issued on Mar 24, 2021.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
SCORPIO	Dec 24, 2021	TEUTEN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Nov 9, 2022
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Nov 9, 2022
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Nov 4, 2022
Termination of the opposition proceedings with revocation of patent
Aug 2, 2022
Advice of delivery
Jul 27, 2022
Advice of delivery
Jul 26, 2022
Decision of the Opposition Division and instruction
Jul 26, 2022
Decision revoking the European patent
Jul 26, 2022
Decision revoking the European patent
Jul 26, 2022
Grounds for the decision (Annex) - opposition
Jul 26, 2022
Means of redress
Jul 26, 2022
Transmittal of decision / summons - opposition
Jul 26, 2022
Transmittal of decision / summons - opposition
Jan 25, 2022
Consolidated list of cited opposition documents
Jan 18, 2022
Communication of a notice of opposition and request to file observations
Jan 18, 2022
Notice of further oppositions to opponent(s)
Jan 12, 2022
Communication of a notice of opposition - first information to patent proprietor
Dec 24, 2021
(Electronic) Receipt
Dec 24, 2021
Citation in opposition procedure - 001
Dec 24, 2021
Citation in opposition procedure - 002
Dec 24, 2021
Citation in opposition procedure - 003
Dec 24, 2021
Citation in opposition procedure - 004
Dec 24, 2021
Citation in opposition procedure - 004
Dec 24, 2021
Citation in opposition procedure - 005
Dec 24, 2021
Citation in opposition procedure - 006
Dec 24, 2021
Citation in opposition procedure - 007
Dec 24, 2021
Citation in opposition procedure - 008
Dec 24, 2021
Citation in opposition procedure - 009
Dec 24, 2021
Citation in opposition procedure - 010
Dec 24, 2021
Citation in opposition procedure - 011
Dec 24, 2021
Citation in opposition procedure - 012
Dec 24, 2021
Citation in opposition procedure - 013
Dec 24, 2021
Letter regarding the opposition procedure (no time limit)
Dec 24, 2021
Notice of opposition
Dec 24, 2021
Notice of opposition
Apr 6, 2021
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Feb 25, 2021
Decision to grant a European patent
Feb 17, 2021
Decision to allow further processing
Feb 5, 2021
(Electronic) Receipt
Feb 5, 2021
French translation of claims
Feb 5, 2021
German translation of the claims
Feb 5, 2021
Letter accompanying subsequently filed items
Feb 5, 2021
Request for further processing
Nov 26, 2020
Application deemed to be withdrawn ( translations of claims/payment missing)
Jun 24, 2020
Bibliographic data of the European patent application
Jun 24, 2020
Communication about intention to grant a European patent
Jun 24, 2020
Text intended for grant (clean copy)
Jun 24, 2020
Text intended for grant (sequence listing)
Jun 24, 2020
Text intended for grant (version for approval)
Jun 23, 2020
Intention to grant (signatures)
Jun 3, 2020
(Electronic) Receipt
Jun 3, 2020
Description
Jun 3, 2020
Letter accompanying subsequently filed items
Jun 3, 2020
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Mar 19, 2020
Communication of the registration of a transfer or change of name and/or address
Feb 11, 2020
Submission concerning change of applicant's address
Feb 3, 2020
Bibliographic data of the European patent application
Feb 3, 2020
Communication about intention to grant a European patent
Feb 3, 2020
Text intended for grant (clean copy)
Feb 3, 2020
Text intended for grant (sequence listing)
Feb 3, 2020
Text intended for grant (version for approval)
Aug 28, 2019
(Electronic) Receipt
Aug 28, 2019
Annex
Aug 28, 2019
Annex
Aug 28, 2019
Letter accompanying subsequently filed items
Aug 28, 2019
Reply to communication from the Examining Division
Jun 18, 2019
Annex to the communication
Jun 18, 2019
Consultation by telephone/in person (with time limit)
Jun 18, 2019
Result of consultation by telephone/in person
Feb 18, 2019
(Electronic) Receipt
Feb 18, 2019
Amended claims with annotations
Feb 18, 2019
Claims
Feb 18, 2019
Letter accompanying subsequently filed items
Feb 18, 2019
Reply to communication from the Examining Division
Jan 8, 2019
Grant of extension of time limit (examination procedure)
Dec 20, 2018
(Electronic) Receipt
Dec 20, 2018
Letter accompanying subsequently filed items
Dec 20, 2018
Request for extension of time limit to communication from the Examining Division
Aug 16, 2018
Annex to the communication
Aug 16, 2018
Communication from the Examining Division
Aug 10, 2018
Examination started
Apr 26, 2018
(Electronic) Receipt
Apr 26, 2018
Amended claims filed after receipt of (European) search report
Apr 26, 2018
Amended claims with annotations
Apr 26, 2018
Amendments received before examination
Apr 26, 2018
Letter accompanying subsequently filed items
Jan 10, 2018
Notification on forthcoming publication of bibliographic data
Nov 16, 2017
Communication concerning correction of deficiencies in written opinion/amendment of application/payment of claims fee
Nov 8, 2017
Communication to designated inventor
Nov 8, 2017
Communication to designated inventor
Nov 8, 2017
Communication to designated inventor
Oct 30, 2017
(Electronic) Receipt
Oct 30, 2017
Certificate of deposit of biological material
Oct 30, 2017
Letter concerning biological material
Oct 30, 2017
Request for entry into the European phase
Oct 17, 2017
Copy of the international preliminary report on patentability
Aug 11, 2017
Information on entry into European phase
Oct 27, 2016
Priority document (electronically transmitted)
Oct 27, 2016
Priority document (electronically transmitted)
Oct 11, 2016
Incoming letter related to PCT RO
Oct 11, 2016
Incoming letter related to PCT RO
Oct 11, 2016
Incoming letter related to PCT RO
Oct 6, 2016
Converted Sequence Listing
Oct 6, 2016
Copy of the international search report
Oct 6, 2016
Letter concerning biological material
Oct 6, 2016
Published international application - A1
Aug 2, 2016
Incoming fax related to PCT RO
Aug 2, 2016
Incoming letter related to PCT RO
Aug 2, 2016
Substitute sheet (R26) - Description
Jun 29, 2016
Communication in cases for which no other form is available
Jun 9, 2016
Written opinion of the ISA, boxes No. I to VIII
Jun 9, 2016
Written opinion of the ISA, cover sheet
Jun 9, 2016
Written opinion of the ISA, supplemental box
Apr 19, 2016
Communication in cases for which no other form is applicable
Apr 8, 2016
Notification of the international application number and of the international filing date
Mar 31, 2016
(Electronic) Receipt
Mar 31, 2016
Abstract
Mar 31, 2016
Claims
Mar 31, 2016
Description
Mar 31, 2016
Document concerning fees and payments
Mar 31, 2016
Drawings
Mar 31, 2016
Electronic request for grant of an International application
Mar 31, 2016
Incoming letter related to PCT RO
Mar 31, 2016
Indications relating to a deposited micro-organism
Mar 31, 2016
Substitute sheet (R26) - Description
Mar 31, 2016
Substitute sheet (R26) Request

EP3277718

BAXALTA

Application Number: EP16712899A
Filing Date: Mar 31, 2016
Status: Revoked; Nov 11, 2022
Publication Date: Mar 24, 2021
External Links: Slate, Register , Google Patents

IP Verse

Dosage Regimen For Anti-Mif Antibodies

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3277718